Lumida
/SBC
⌘K
SBC Medical Group Holdings Inc

SBC Medical Group Holdings Inc

SBC
$3.08USD-2.84%-0.09 today

MARKET CAP

316.8M

P/E (TTM)

8.1x

FWD P/E

6.6x

DAY RANGE

$3 – $3

52W RANGE

$3
$6

AI Summary

Stalk
TrimMedium

SBC remains in a Stage 4 decline with persistent lower highs and lower lows and price trading below all major EMAs. The medium-term bias is bearish, as the active Post-Capitulation pattern signals only exhaustion without structural repair. Extreme oversold conditions counsel caution, so execution will focus on trimming into rallies toward the 9/20 EMA resistance zone.

  • Underlying revenue +111% YoY and EBITDA +117% YoY ex-fee changes
  • 72% repeat customer rate bolstered by multi-brand segmentation
  • Total revenue fell 9% YoY in Q1 due to fee structure revisions
Full analysis →
Insider Trades3 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Apr 28, 2026SellSBCYoshiyuki AikawaChairman and CEO465,000$3.02$316.8M-46.43%+10.79%$1.4M-0.59%Stalk
Apr 21, 2026SellSBCYoshiyuki AikawaChairman and CEO3,100,000$3.02$316.8M-46.43%+10.79%$9.4M-3.76%Stalk
Mar 6, 2026SellSBCYoshiyuki AikawaChairman and CEO4,422,900$2.12$316.8M-46.43%+10.79%$9.4M-82.32%Stalk